RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanxi Zhendong Pharmaceutical Co Stock

Shanxi Zhendong Pharmaceutical Co Revenue 2024

Shanxi Zhendong Pharmaceutical Co Revenue

3.63 B CNY

Ticker

300158.SZ

ISIN

CNE100000YR9

In 2024, Shanxi Zhendong Pharmaceutical Co's sales reached 3.63 B CNY, a -2.75% difference from the 3.73 B CNY sales recorded in the previous year.

The Shanxi Zhendong Pharmaceutical Co Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
20233.6349,59
20223.7349,20
20215.0959,60
20204.8562,36
20194.464,57
20183.4265,44
20173.7357,64
20163.2844,36
20152.2645,29
20141.9243,56
20131.6649,02
20121.3953,92
20111.2852,16
20100.9357,36
20090.5376,58
20080.4678,53
20070.3285,32

Shanxi Zhendong Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shanxi Zhendong Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shanxi Zhendong Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shanxi Zhendong Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shanxi Zhendong Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shanxi Zhendong Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shanxi Zhendong Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shanxi Zhendong Pharmaceutical Co’s growth potential.

Shanxi Zhendong Pharmaceutical Co Revenue, EBIT and net profit per share

DateShanxi Zhendong Pharmaceutical Co RevenueShanxi Zhendong Pharmaceutical Co EBITShanxi Zhendong Pharmaceutical Co Net Income
20233.63 B undefined-85.7 M undefined-43.98 M undefined
20223.73 B undefined-64.07 M undefined-51.29 M undefined
20215.09 B undefined181.55 M undefined2.62 B undefined
20204.85 B undefined330.1 M undefined262 M undefined
20194.4 B undefined228.2 M undefined142.8 M undefined
20183.42 B undefined76.6 M undefined-147.4 M undefined
20173.73 B undefined383.4 M undefined301.5 M undefined
20163.28 B undefined234.9 M undefined203.1 M undefined
20152.26 B undefined73.2 M undefined64.6 M undefined
20141.92 B undefined43.8 M undefined42 M undefined
20131.66 B undefined97.1 M undefined74 M undefined
20121.39 B undefined76.5 M undefined91.5 M undefined
20111.28 B undefined107.6 M undefined119.8 M undefined
2010930.3 M undefined115.7 M undefined92.1 M undefined
2009528.7 M undefined91.2 M undefined68 M undefined
2008461.1 M undefined85.2 M undefined59.4 M undefined
2007315.3 M undefined63.6 M undefined39.2 M undefined

Shanxi Zhendong Pharmaceutical Co stock margins

The Shanxi Zhendong Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shanxi Zhendong Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shanxi Zhendong Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shanxi Zhendong Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Shanxi Zhendong Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shanxi Zhendong Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shanxi Zhendong Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shanxi Zhendong Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shanxi Zhendong Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shanxi Zhendong Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shanxi Zhendong Pharmaceutical Co Margin History

Shanxi Zhendong Pharmaceutical Co Gross marginShanxi Zhendong Pharmaceutical Co Profit marginShanxi Zhendong Pharmaceutical Co EBIT marginShanxi Zhendong Pharmaceutical Co Profit margin
202349.59 %-2.36 %-1.21 %
202249.2 %-1.72 %-1.38 %
202159.6 %3.56 %51.38 %
202062.36 %6.81 %5.4 %
201964.57 %5.19 %3.25 %
201865.44 %2.24 %-4.31 %
201757.64 %10.27 %8.08 %
201644.36 %7.16 %6.19 %
201545.29 %3.24 %2.86 %
201443.56 %2.28 %2.19 %
201349.02 %5.85 %4.46 %
201253.92 %5.52 %6.6 %
201152.16 %8.4 %9.35 %
201057.36 %12.44 %9.9 %
200976.58 %17.25 %12.86 %
200878.53 %18.48 %12.88 %
200785.32 %20.17 %12.43 %

Shanxi Zhendong Pharmaceutical Co Aktienanalyse

What does Shanxi Zhendong Pharmaceutical Co do?

Shanxi Zhendong Pharmaceutical Co Ltd is a Chinese pharmaceutical company based in the Shanxi province. The company was founded in 1996 and has since specialized in the production and distribution of pharmaceutical products. The business model of Shanxi Zhendong Pharmaceutical Co Ltd is based on the development and production of medicines for the Chinese market. The company focuses on specific therapeutic areas such as gastroenterology, cardiology, oncology, and respiratory diseases. The different divisions of the company include research and development, production, and distribution of pharmaceutical products. The company has modern production facilities that meet the highest international quality standards. Through the use of advanced technologies and a high quality standard, Shanxi Zhendong Pharmaceutical Co Ltd ensures a high product quality and safety. Among the products offered by Shanxi Zhendong Pharmaceutical Co Ltd are a variety of medicines. These include antibiotics, antihypertensives, anti-cancer drugs, antipyretics, and analgesics. The company also offers a range of dietary supplements, vitamins, and medications for the treatment of women's health issues and children. The goal of Shanxi Zhendong Pharmaceutical Co Ltd is to develop innovative products through continuous research and development to meet the increasing demands of the Chinese healthcare market. The company maintains strict production and quality control to ensure the highest safety standards and efficacy. Overall, Shanxi Zhendong Pharmaceutical Co Ltd has established a strong position in the Chinese pharmaceutical market. The company is committed to leveraging this growth potential and strengthening its presence in both the national and international markets. Shanxi Zhendong Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Shanxi Zhendong Pharmaceutical Co's Sales Figures

The sales figures of Shanxi Zhendong Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shanxi Zhendong Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shanxi Zhendong Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shanxi Zhendong Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shanxi Zhendong Pharmaceutical Co stock

How much revenue did Shanxi Zhendong Pharmaceutical Co generate this year?

Shanxi Zhendong Pharmaceutical Co has achieved a revenue of 3.63 B CNY this year.

How much was the turnover of the company Shanxi Zhendong Pharmaceutical Co compared to the previous year?

The revenue of Shanxi Zhendong Pharmaceutical Co has increased by -2.75% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Shanxi Zhendong Pharmaceutical Co?

The revenue of Shanxi Zhendong Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Shanxi Zhendong Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Shanxi Zhendong Pharmaceutical Co so important for investors?

The revenue of Shanxi Zhendong Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Shanxi Zhendong Pharmaceutical Co pay?

Over the past 12 months, Shanxi Zhendong Pharmaceutical Co paid a dividend of 2.7 CNY . This corresponds to a dividend yield of about 51.72 %. For the coming 12 months, Shanxi Zhendong Pharmaceutical Co is expected to pay a dividend of 2.7 CNY.

What is the dividend yield of Shanxi Zhendong Pharmaceutical Co?

The current dividend yield of Shanxi Zhendong Pharmaceutical Co is 51.72 %.

When does Shanxi Zhendong Pharmaceutical Co pay dividends?

Shanxi Zhendong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, June, October, June.

How secure is the dividend of Shanxi Zhendong Pharmaceutical Co?

Shanxi Zhendong Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Shanxi Zhendong Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 2.7 CNY are expected. This corresponds to a dividend yield of 51.72 %.

In which sector is Shanxi Zhendong Pharmaceutical Co located?

Shanxi Zhendong Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanxi Zhendong Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanxi Zhendong Pharmaceutical Co from 5/9/2022 amounting to 2.7 CNY, you needed to have the stock in your portfolio before the ex-date on 5/9/2022.

When did Shanxi Zhendong Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 5/9/2022.

What was the dividend of Shanxi Zhendong Pharmaceutical Co in the year 2023?

In the year 2023, Shanxi Zhendong Pharmaceutical Co distributed 0.17 CNY as dividends.

In which currency does Shanxi Zhendong Pharmaceutical Co pay out the dividend?

The dividends of Shanxi Zhendong Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shanxi Zhendong Pharmaceutical Co

Our stock analysis for Shanxi Zhendong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanxi Zhendong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.